These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9342577)

  • 21. Variability in activity and results from drug assessments by pharmacy and therapeutics committees in Spanish hospitals.
    Puigventós Latorre F; Santos-Ramos B; Ortega Eslava A; Durán-García ME;
    Farm Hosp; 2011; 35(6):305-14. PubMed ID: 21497125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug approval processes in Australian Paediatric Hospitals.
    Sinha YK; Craig JC; Barclay P; Taitz J; South M; Coulthard K; Pearson C; Erickson S; Brien JE
    Arch Dis Child; 2010 Sep; 95(9):739-44. PubMed ID: 20584852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The P&T committee: Clinical Hospital Center, Zagreb, Yugoslavia.
    Vrhovac B; Francetic I
    Hosp Formul; 1984 Dec; 19(12):1158-9, 1162. PubMed ID: 10269439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation and influence of individuals and committees that decide on drug availability in HMOs.
    Barner JC; Thomas J
    Am J Health Syst Pharm; 1998 Jan; 55(1):56-61. PubMed ID: 9437476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.
    Shankar PR; Humagain B; Piryani RM; Jha N; Osti B
    Pharm World Sci; 2009 Apr; 31(2):241-5. PubMed ID: 19058026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-use evaluation programs in short-term-care general hospitals.
    Terry AK; Draugalis JR; Bootman JL
    Am J Hosp Pharm; 1993 May; 50(5):940-4. PubMed ID: 8506873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
    Plumridge RJ; Stoelwinder JU; Rucker TD
    Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A national survey of hospital ethics committees.
    Youngner SJ; Jackson DL; Coulton C; Juknialis BW; Smith EM
    Crit Care Med; 1983 Nov; 11(11):902-5. PubMed ID: 6627962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Health care ethics committees in German university clinics. A survey of all medical directors and directors of nursing].
    Vollmann J; Burchardi N; Weidtmann A
    Dtsch Med Wochenschr; 2004 May; 129(22):1237-42. PubMed ID: 15170579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the performance of Drug and Therapeutics Committees in hospitals--a quasi-experimental study in Laos.
    Vang C; Tomson G; Kounnavong S; Southammavong T; Phanyanouvong A; Johansson R; Eriksson B; Wahlstrom R
    Eur J Clin Pharmacol; 2006 Jan; 62(1):57-63. PubMed ID: 16372173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription of drugs not listed in a clinic's pharmacopoeia: supervision by clinical pharmacologists.
    Harder S; Thürmann P; Huber T; Rietbrock N
    Eur J Clin Pharmacol; 1991; 40(6):561-4. PubMed ID: 1884736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of medicines in Chilean public hospitals: an exploratory study.
    Collao JF; Smith F; Barber N
    BMC Health Serv Res; 2013 Jan; 13():10. PubMed ID: 23294543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and cost savings of therapeutic interchange among U.S. hospitals.
    Schachtner JM; Guharoy R; Medicis JJ; Newman N; Speizer R
    Am J Health Syst Pharm; 2002 Mar; 59(6):529-33. PubMed ID: 11908245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.